BERLYNN CHING: Open Payments
NPI 1306199906 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 10 payments from 5 companies in 2025. Trend: 2023 $1,128 · 2024 $534 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $248 |
| E.R. Squibb & Sons, L.L.C. | 3 | $171 |
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Alkermes, Inc. | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: INVEGA SUSTENNA, COBENFY, INGREZZA, LYBALVI, UZEDY.
Industry payments across CA — which companies pay providers there.
